Breaking News Instant updates and real-time market news.

2019-02-13 08:48:30 VTGN VistaGen Therapeutics $1.72 -0.03 (-1.71%) 08:48 02/13/19 02/13 08:48 02/13/19 08:48	VistaGen Therapeutics receives notice of allowance from USPTO for PH10 patent VistaGen Therapeutics announced that the U.S. Patent and Trademark Office, or USPTO, has provided a notice of allowance for a patent related to methods of treating depression with PH10, VistaGen's investigational new generation CNS nasal spray in Phase 2 development for major depressive disorder. Counterpart foreign patents have already issued in Europe, Japan and several other countries. In a small exploratory Phase 2a clinical study, at microgram doses, PH10 nasal spray was observed to have rapid-onset antidepressant effects, without systemic exposure, psychological side effects or safety concerns.
VTGN VistaGen Therapeutics $1.72 -0.03 (-1.71%) 05/24/18 OPCO 05/24/18 INITIATION Target $6 OPCO Outperform VistaGen Therapeutics initiated with an Outperform at Oppenheimer Oppenheimer analyst Jay Olson started VistaGen Therapeutics with an Outperform rating and $6 price target. The company is "underappreciated and undervalued, with a novel, potentially best-in-class, rapid acting oral antidepressant," Olson tells investors in a research note. He believes AV-101 may offer ketamine-like efficacy without the side effects or inconvenience and that trial readouts by mid-2019 could unlock "substantial shareholder value." 05/25/18 05/25/18 INITIATION On The Fly: Top five analyst initiations Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Enanta (ENTA) initiated with an Outperform at Oppenheimer. 2. VistaGen Therapeutics (VTGN) initiated with an Outperform at Oppenheimer. 3. Engility (EGL) initiated with a Buy at Stifel. 4. ManTech (MANT) initiated with a Hold at Stifel. 5. SAIC (SAIC) initiated with a Hold at Stifel. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, Reference Link 06/27/18 MAXM 06/27/18 INITIATION Target $6 MAXM Buy VistaGen Therapeutics initiated with a Buy at Maxim Maxim initiated VistaGen Therapeutics with a Buy and $6 price target. 06/27/18 MAXM 06/27/18 INITIATION Target $6 MAXM Buy VistaGen Therapeutics initiated with a Buy at Maxim As reported earlier, Maxim analyst Caroline Palomeque initiated VistaGen Therapeutics (VTGN) with a Buy rating and a price target of $6 based on its lead drug candidate, AV-101, an oral antidepressant targeting modulation of the NMDA receptor which is an emerging new class of antidepressants. The analyst notes that while Johnson & Johnson (JNJ) and Allergan (AGN) have first mover advantage in the NMDA class, their respective intranasal and IV in-office administration differentiates AV-101 as an oral at-home alternative. Palomeque notes the company's is progressing with its clinical development, as AV-101 undergoes phase 2 studies in treatment resistant major depressive disorder and adjunctive therapy in frontline failed patients, with data expected in the second half of this year and first half of 2019 respectively.

2019-02-13 08:48:30

VTGN

VistaGen Therapeutics

$1.72: -0.03 (-1.71%)

08:48

02/13/19

02/13

08:48

02/13/19

08:48

VistaGen Therapeutics receives notice of allowance from USPTO for PH10 patent

VistaGen Therapeutics announced that the U.S. Patent and Trademark Office, or USPTO, has provided a notice of allowance for a patent related to methods of treating depression with PH10, VistaGen's investigational new generation CNS nasal spray in Phase 2 development for major depressive disorder. Counterpart foreign patents have already issued in Europe, Japan and several other countries. In a small exploratory Phase 2a clinical study, at microgram doses, PH10 nasal spray was observed to have rapid-onset antidepressant effects, without systemic exposure, psychological side effects or safety concerns.

VTGN VistaGen Therapeutics

$1.72: -0.03 (-1.71%)

05/24/18: OPCO

05/25/18

06/27/18: MAXM

06/27/18: MAXM

TODAY'S FREE FLY STORIES

CZR Caesars $9.42 -0.21 (-2.18%) 18:06 02/21/19 02/21 18:06 02/21/19 18:06 Hot Stocks	Breaking Hot Stocks news story on Caesars » Caesars says will not… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	21 Feb
LNT Alliant Energy $45.63 0.45 (1.00%) 18:03 02/21/19 02/21 18:03 02/21/19 18:03 Earnings	Breaking Earnings news story on Alliant Energy » Alliant Energy sees FY19… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	22 Feb
LNT Alliant Energy $45.63 0.45 (1.00%) 18:02 02/21/19 02/21 18:02 02/21/19 18:02 Earnings	Alliant Energy reports Q4 EPS 36c, conseensus 35c » Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	22 Feb
BVN Buenaventura $16.53 -0.37 (-2.19%) 17:59 02/21/19 02/21 17:59 02/21/19 17:59 Earnings	Buenaventura reports Q4 EPS (29c), consensus 5c » Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	01 Mar 12 Mar 12 Mar
KHC Kraft Heinz $48.19 -0.05 (-0.10%) 17:58 02/21/19 02/21 17:58 02/21/19 17:58 Hot Stocks	Kraft Heinz says expects to face profit headwinds in 2019 » Says: Expects EBITDA down… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	21 Feb

GABC German American Bancorp $31.59 (0.00%) , CZFC Citizens First $23.30 1.87 (8.73%) 17:56 02/21/19 02/21 17:56 02/21/19 17:56 Hot Stocks	German American, Citizens First announce merger pact » German American Bancorp,… GABC German American Bancorp $31.59 (0.00%) CZFC Citizens First $23.30 1.87 (8.73%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
TSLA Tesla $291.18 -11.33 (-3.75%) 17:56 02/21/19 02/21 17:56 02/21/19 17:56 Periodicals	Lucid Motors is 'working' on an all electric SUV, Verge says » Electric vehicle startup… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	21 Feb 25 Feb 18 Mar 19 Mar
CZR Caesars $9.42 -0.21 (-2.18%) 17:54 02/21/19 02/21 17:54 02/21/19 17:54 Hot Stocks	Caesars sees FY19 same-store capex $375M-$450M » Sees FY19 development… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	21 Feb
PBA Pembina Pipeline $36.44 -0.235 (-0.64%) 17:54 02/21/19 02/21 17:54 02/21/19 17:54 Earnings	Pembina Pipeline reports Q4 EPS C$0.66 vs C$0.83 last year » Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	22 Feb
KHC Kraft Heinz $48.19 -0.05 (-0.10%) 17:53 02/21/19 02/21 17:53 02/21/19 17:53 Hot Stocks	Kraft Heinz continues to fall, now down 16.5% to $40.25 » In after-hours trading,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	21 Feb

CZR Caesars $9.42 -0.21 (-2.18%) 17:52 02/21/19 02/21 17:52 02/21/19 17:52 Hot Stocks	Caesars says in discussions with Carl Icahn after his disclosed stake » Comments from Q4 earnings… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	21 Feb
HRS Harris $164.55 -0.62 (-0.38%) 17:48 02/21/19 02/21 17:48 02/21/19 17:48 Hot Stocks	Harris awarded $168.8M Navy contract modification » Harris has been awarded a… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
KHC Kraft Heinz $48.19 -0.05 (-0.10%) 17:45 02/21/19 02/21 17:45 02/21/19 17:45 Hot Stocks	Kraft Heinz to cut quarterly dividend to 40c from 62.5c per share » Says: Higher supply chain… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	21 Feb
HON Honeywell $152.60 -1.2 (-0.78%) 17:43 02/21/19 02/21 17:43 02/21/19 17:43 Hot Stocks	Honeywell awarded not-to-exceed $150M Air Force contract for ATTAM Phase 1 » Honeywell has been… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	29 Apr
BA Boeing $417.48 -4.13 (-0.98%) 17:40 02/21/19 02/21 17:40 02/21/19 17:40 Hot Stocks	Tapestry awarded not-to-exceed $259M Air Force contract for WPS » Tapestry Solutions, a… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	11 Mar 28 May

INFN Infinera $4.87 -0.02 (-0.41%) 17:39 02/21/19 02/21 17:39 02/21/19 17:39 Earnings	Infinera sees Q1 EPS (27c) plus/minus 2c, consensus (19c) » Sees Q1 GAAP revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	21 Feb 25 Feb 26 Feb 27 Feb 28 Feb
CRON Cronos Group $22.45 0.22 (0.99%) , MO Altria Group $50.38 -0.14 (-0.28%) 17:37 02/21/19 02/21 17:37 02/21/19 17:37 Hot Stocks	Cronos Group shareholders approve C$2.4B investment from Altria Group » Cronos Group (CRON)… CRON Cronos Group $22.45 0.22 (0.99%) MO Altria Group $50.38 -0.14 (-0.28%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	21 Feb 21 Feb
BAH Booz Allen $53.64 -0.105 (-0.20%) , GD General Dynamics $171.66 -2.78 (-1.59%) … 17:36 02/21/19 02/21 17:36 02/21/19 17:36 Hot Stocks	Booz Allen, General Dynamics, Leidos and SAIC awarded DTRA contracts » Booz Allen (BAH), General… BAH Booz Allen $53.64 -0.105 (-0.20%) GD General Dynamics $171.66 -2.78 (-1.59%) LDOS Leidos $62.87 1.175 (1.90%) SAIC SAIC $75.73 -0.75 (-0.98%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	28 May
INFN Infinera $4.87 -0.02 (-0.41%) 17:35 02/21/19 02/21 17:35 02/21/19 17:35 Earnings	Infinera reports Q4 EPS (25c), consensus (27c) » Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	21 Feb 25 Feb 26 Feb 27 Feb 28 Feb
ECIFF EDF $0.00 (0.00%) 17:33 02/21/19 02/21 17:33 02/21/19 17:33 Downgrade	EDF rating change » EDF downgraded to Neutral… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial

LEE Lee Enterprises $2.69 0.075 (2.87%) 17:32 02/21/19 02/21 17:32 02/21/19 17:32 Hot Stocks	Lee Enterprises' TownNews acquires CMS business from GTxcel » Lee Enterprises announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
CENX Century Aluminum $9.30 0.12 (1.31%) 17:31 02/21/19 02/21 17:31 02/21/19 17:31 Earnings	Century Aluminum reports Q4 EPS (43c), consensus (53c) » Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	21 Feb
EXEL Exelixis $21.22 (0.00%) 17:30 02/21/19 02/21 17:30 02/21/19 17:30 Initiation	Exelixis initiated » Exelixis initiated with a… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
EPSN Epsilon Energy $0.00 (0.00%) 17:30 02/21/19 02/21 17:30 02/21/19 17:30 Hot Stocks	Epsilon Energy sees 2019 production growth of 27%-33% y/y » The company anticipates… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
SSRM SSR Mining $14.13 0.245 (1.76%) 17:29 02/21/19 02/21 17:29 02/21/19 17:29 Earnings	SSR Mining sees FY19 gold production 395,000 equivalent ounces » At the Marigold mine,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	22 Feb

Events

Earnings calls, analyst events, roadshows and more

Today at 18:30

CFTC Chairman Goamcarlo to Speak at Forum Government Event

Crystal Gateway Marriott--1700 Jefferson Davis Hwy, Arlington, VA
IQ
Today at 19:00

iQIYI - IQ Conference Calls
BIDU
Today at 20:15

Baidu - BIDU Conference Calls
BBX
Tomorrow at 00:00

BBX Capital - BBX Conference Calls
Tomorrow at 00:00

Japan Corporate Day 2019 Winter Conferences

Sinagpore/Hong Kong
Tomorrow at 00:00

18th Annual Korea Conference Conferences

Seoul
Tomorrow at 00:00

10th Annual Capital Link Greek Shipping Forum Conferences

Divani Caravel Hotel, Athens
Tomorrow at 00:00

Transplantation & Cellular Therapy Meetings of ASBMT & CIBMTR Conferences

Hilton Americas, Houston, TX
Tomorrow at 00:00

2019 Agricultural Outlook Forum Conferences

Crystal Gateway Marriott Hotel, Arlington, VA
NWL ...
Tomorrow at 00:00

CAGNY Conference 2019 Conferences

New York, NY

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	AI X AI Arlington Asset Investment Spot Secondary Managers: Morgan Stanley & JMP Securities Priced at: $8.33 6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ARR X ARR ARMOUR Residential Spot Secondary Managers: Morgan Stanley & Barclays, Citi, Credit Suisse, Goldman Sachs & JPMorgan Priced at: $20.33 7.2M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CPT X CPT Camden Property Spot Secondary Managers: BofA/Merrill & Deutsche Bank Priced at: $97.85 3.375M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial NRZ X NRZ New Residential Spot Secondary Managers: Morgan Stanley, Credit Suisse & JPMorgan Priced at: $16.50 40.3M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial OVID X OVID Ovid Therapeutics Spot Secondary Managers: Cowen & William Blair Priced at: $2.00 12.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SNNA X SNNA Sienna Biopharmaceuticals Spot Secondary Managers: Cowen & BMO Capital Priced at: $2.50 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	RWLK X RWLK ReWalk Robotics Spot Secondary Managers: H.C. Wainwright Priced at: $.23 19M Shares
Thurs	ACAM X ACAM Acamar Partners IPO Managers: Goldman Sachs & Deutsche Bank Priced at: $10.00 30M Shares
Fri	No deals

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	TRIL X TRIL Trillium Therapeutics Spot Secondary Managers: Cowen $0.80 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

View All Syndicate Announcements »

VistaGen Therapeutics receives notice of allowance from USPTO for PH10 patent

TODAY'S FREE FLY STORIES

Get Full Fly Access